Mast Therapeutics (MSTX) Plans to Hold First-Ever Investor Day
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Mast Therapeutics (MSTX) Reports Cash and Equivalents of $50M
October 7, 2015 12:57 PM EDTOn October 7, 2015, Mast Therapeutics, Inc. (NYSE: MSTX) announced that its cash, cash equivalents and investment securities were approximately $50 million as of September 30, 2015.
Mast Therapeutics, Inc. corporate presentation, October 7, 2015
... More